Professional Documents
Culture Documents
INTRODUCTION
System Overview .......................................................................................................................1
SURGICAL TECHNIQUE
Step 1 - Patient Positioning........................................................................................................2
Step 2 - Disc Access...................................................................................................................3
Step 3 - Discectomy....................................................................................................................4
Step 4 - Decompression.............................................................................................................6
Step 5 - Trial Sizing.....................................................................................................................7
Step 6 - Endplate Preparation - Drilling.....................................................................................10
Step 7 - Implantation..................................................................................................................12
Step 8 - Implant Fixation.............................................................................................................14
Step 9 - Final Placement & Closure...........................................................................................15
SYSTEM OVERVIEW
Cervical spine arthroplasty is an innovative and effective means of stabilizing the spine and offering relief of the intractable symptoms and
physiological findings associated with cervical spondylosis and radiculopathy. Anterior cervical discectomy and fusion (ACDF), though
effective in managing symptomatic relief has the disadvantage of converting the operating segment of the cervical spine into an immobile
fused unit. The most pronounced disadvantage of this treatment is the overall lack of mobility and increased risk of adjacent degenerative
disc disease.
The NuNec® Cervical Arthroplasty System is intended to preserve segmental motion, offer symptomatic relief and reduce reoperation due
to pseudoarthrosis.
PATIENT SELECTION
Proper patient selection plays a critical role in the success of cervical spine arthroplasty. The NuNec Cervical Arthroplasty System is
primarily indicated for cervical soft disc disease. Ideal candidates are patients with radiculopathy and focal disc disease. Patients with
advanced spondylotic disease, especially patients with diffuse spondylosis or significant anterior/posterior osteophytes, should not be
treated with anterior cervical arthroplasty. One potential effect of these conditions, along with individual patient anatomy, may prevent ideal
engagement of the fixation cams. If sufficient engagement is not accomplished, consideration should be made for alternate treatment as
determined appropriate by the healthcare professional.
ROTATING CAMS
for superior fixation*
Typical 22°
*As compared to press-fit and spike style fixation systems evaluated. Data on file at RTI Surgical, Inc.
†
Varies depending on device size. Data on file at RTI Surgical, Inc.
1
SURGICAL TECHNIQUE
1 PATIENT POSITIONING
Place the patient in the supine position with the head and
neck supported in a neutral position. A rolled pillow may
be placed under the neck to support and maintain proper
positioning (Figure 1). Care must be taken not to place the
neck in extension.
Site Identification
Identify the location of the affected operative disc level
and corresponding incision site using A/P and lateral
fluoroscopy while marking the skin with sterile ink.
2
SURGICAL TECHNIQUE
2 DISC ACCESS
Figure 2
After the incision is made, retract using handheld retractors
(Figure 2), to expose the anterior vertebral column and the
adjacent longus colli muscles.
Note: Identify the midline by using the borders of the longus colli
muscles, the anterior longitudinal ligament and the natural slope
of the anterior vertebral bodies as landmarks. The vertebral body
is preliminarily marked in the midline using electrocautery or other
methods.
3
SURGICAL TECHNIQUE
3 DISCECTOMY
Figure 3A
Verify the midline by placing distraction posts or a
localizing device in line with the spinous processes
using true A/P fluoroscopy. Equal lateral margins of the
vertebral body and uncovertebral joints confirm midline
(Figure 3B).
Figure 3B
Figure 3C
4
SURGICAL TECHNIQUE
5
SURGICAL TECHNIQUE
4 DECOMPRESSION
6
SURGICAL TECHNIQUE
Surgical Tip: Start trialing with the smallest footprint and proceed
INCORRECT
to the next larger size until an appropriate footprint is determined.
INCORRECT
CORRECT WIDTH
Figure 5B
7
SURGICAL TECHNIQUE
Figure 5C
Figure 5D
71-TRL-S-(X)-F 5, 6 or 7mm
71-TRL-SD-(X)-F 5, 6 or 7mm
71-TRL-M-(X)-F 5, 6 or 7mm
71-TRL-MD-(X)-F 5, 6 or 7mm
8
SURGICAL TECHNIQUE
Gently tap trial spacer into the targeted disc space starting
with the smallest height first and increasing in size until the
spacer fits snugly in the disc space (Figure 5E). Oversizing COR Marker
the device will limit disc motion and may lead to instability.
INCORRECT
Using the indicator on the trial spacer, verify that the center
of rotation (COR) will be placed approximately at the
midline of the inferior vertebral body (Figure 5E). Perform
additional discectomy as necessary to achieve proper
position.
CORRECT HEIGHT
Once the trial spacer size and position have been
determined, leave the trial spacer attached to the inserter
Figure 5E
and prepare the site for implantation. Prior to drilling, verify
the trial spacer is parallel in a transverse plane to both
the superior and inferior endplates (Figure 5F) and that
distraction has been removed.
Figure 5F
9
SURGICAL TECHNIQUE
Note: The trial spacer is not secure until two drills are bored into
the vertebral body, therefore, it is important not to remove the trial
inserter until after the two superior drills have been bored into the
superior vertebral body.
Figure 6B
Figure 6C
10
SURGICAL TECHNIQUE
Surgical Tip: Keep the trial spacer in the affected disc space until
after the NuNec implant is selected and loaded onto the implant
inserter.
Figure 6E
11
SURGICAL TECHNIQUE
Select the appropriate implant based on the footprint size 71-SD-X or 73-SD-X Small Deep (14.5 x 14mm) 5, 6 or 7mm
and disc height indicated by the trial spacer used in the 71-M-X or 73-M-X Medium (14.5 x 17mm) 5, 6 or 7mm
procedure. Select the cam whose color matches both the 71-MD-X or 73-MD-X Medium Deep (17 x 17mm) 5, 6 or 7mm
trial spacer and drills used in the prior step. Table 3 - Implant Sizing
With the locking arm up, align the posts of the implant
inserter with the bores in the implant and push the
leading edge of the implant inserter into the NuNec
implant (Figure 7A). Verify engagement (Figure 7B).
Once in position, flip the locking arm down to lock the Figure 7A
Verify all four posts of the inserter are engaged with the
implant (Figure 7D).
Verify:
Figure 7C
Figure 7D
12
SURGICAL TECHNIQUE
Figure 7G
13
SURGICAL TECHNIQUE
8 IMPLANTATION FIXATION
Implant Spacer
Turn the superior cams from medial to lateral, i.e. turn
Figure 8A
the right cam clockwise (Figure 8A). Turn the left cam
counterclockwise (Figure 8B). Always turn the cams
slowly to ensure complete engagement into the vertebral
endplates and prevent over-rotation.
Note: Unlocked cams appear with the black portion of the cam
heads facing toward the implant. When locked, the black portion
of the cam heads should face outward (toward the vertebral
bodies) (Figure 8C). Use lateral fluoroscopy for final verification
of complete implant engagement.
Figure 8B
Figure 8C
14
SURGICAL TECHNIQUE
Figure 9B
15
APPENDIX A:
LOADING ALTERNATIVE
Using the implant inserter with locking arm up, align the posts Figure A1
with the bores in the implant and push the leading edge of
the implant inserter into the NuNec implant (Figure A1). Verify
engagement (Figure A2). Once in position, flip the locking arm
down to lock the implant onto the implant inserter (Figure A3).
Verify all four posts of the implant inserter are engaged with the
implant (Figure A4).
Verify:
Figure A3
Figure A4
16
INDICATIONS
& WARNINGS
INDICATIONS Use care when handling the NuNec device to ensure that it does
not come in contact with objects that may damage the implant.
The NuNec is indicated in skeletally mature patients with cervical
degenerative disc disease (DDD) for reconstruction of the disc Use aseptic technique when removing the NuNec Cervical Disc
from C3-C7. DDD is defined as intractable radiculopathy and/ implant components from the innermost packaging.
or myelopathy with at least one of the following conditions Surgical implants must never be re-used or re-implanted. Even
confirmed via radiographic studies (e.g., CT, MRI, x-rays, etc.): though the device appears undamaged, it may have small defects
herniated nucleus pulposus, spondylosis (defined by the and internal stress patterns that may lead to early breakage.
presence of osteophytes), and/or the loss of disc height. Patients
should have failed six weeks of non-operative treatment prior to Patients should be instructed in postoperative care procedures
receiving the NuNec Cervical Disc Replacement device. The and should be advised of the importance of adhering to these
device is to be implanted via an open anterior approach. procedures for successful treatment with the NuNec Cervical
Disc Replacement. This includes but is not limited to avoidance
CONTRAINDICATIONS of heavy lifting, repetitive bending, and high-impact exercise or
athletic activity for 60 days postoperative.
Do not apply in cases of:
The NuNec Cervical Disc implant should not be used with
• Active systemic infection or infection localized to the site of components or instruments of spinal systems from other
implantation manufacturers. See surgical technique manual for step-by-step
• Osteoporosis defined as DEXA bone density measured T instructions.
score < -2.5
• Cervical instability on neutral resting flexion/extension or
WARNING
lateral radiographs (indicated by translation > 3mm, and/or >
11° of rotational difference to either adjacent level) The surgeon must read the physician’s surgical technique prior
• Allergy or sensitivity to PEEK, Titanium or Tantalum to implanting the NuNec. A lack of adequate training may lead
• Severe spondylolisthesis characterized by bridging to a higher incidence of adverse events, including neurological
osteophytes or a loss of disc height > 50% complications. Correct placement of the NuNec implant is
• Conditions which may lead to bone formation (e.g., essential to optimal performance.
heterotopic ossification, fusion) Due to the proximity of vascular and neurological structures
• Clinically compromised vertebral bodies at the affected to the implantation site, there are risks of serious or fatal
level due to current or past trauma (e.g., by radiographic hemorrhage and risks of neurological damage with the use of
appearance of fracture callus, malunion, or nonunion) this device. Serious or fatal hemorrhage may also occur if the
great vessels are eroded or punctured during implantation
PRECAUTION
and are subsequently damaged due to breakage of implants,
The safety and effectiveness of this device has not been migration of implants, or if pulsatile erosion of the vessels occur
established in patients with the following conditions: because of close apposition of the implants.
• Skeletally immature patients This system has not been evaluated for safety and compatibility
• Clinically significant cervical instability in the MR environment. This system has not been tested for
• Prior fusion at adjacent cervical level heating or migration in the MR environment.
• Severe facet joint pathology of involved vertebral bodies
• Prior surgery at affected level
• Osteopenia, osteomalacia, Paget’s disease or other
See insert for complete labeling limitations related
metabolic bone disease (verified via DEXA T-score)
to this device.
• Neck or arm pain of unknown etiology
• Spinal metastases
Manufactured by Pioneer Surgical Technology, Inc.
• Chronic or acute renal failure or history of renal disease
DBA RTI Surgical.
• Taking medications known to potentially interfere with bone/
soft tissue healing (e.g. steroids)
• Severe diabetes mellitus requiring daily insulin treatment
• Systemic disease including AIDS, HIV, and Hepatitis
• Active malignancy
18
19
Pioneer Surgical Technology BV
Voorveste 7, 3992 DC Houten
The Netherlands
t: 31 30 693 47 20
f: 31 30 693 47 21
www.rtisurgical.com
info-houten@rtix.com
Manufactured by:
Pioneer Surgical Technology, Inc. Pioneer Surgical Technology, Inc.
® indicates U.S. trademark registration. All trademarks and/or
375 River Park Circle
images are the property of their respective owners or holders.
Marquette, MI 49855 USA
Pioneer Surgical Technology, Inc. is a wholly owned t: 800.557.9909
subsidiary of RTI Surgical, Inc. www.rtisurgical.com